«Hormonal healthcare can be intimidating, since it touches on the most intimate parts of our lives. Kindly wants to make it accessible to more people, with a combination of at-home diagnostic tests (including semen tests and tests for polycystic ovary syndrome), telehealth consultations and supplements.»

«The Bangalore-based startup, which has ambitions to expand into global markets, announced today it has raised a $3.25 million seed round from investors including Y Combinator, Olive Tree, Soma, Goodwater and Gaingels.»

«Kindly has two product lines, KindlyHis and KindlyHers. KindlyHers will launch a PCOS predictive test that can help women diagnose and manage PCOS. It also sells routine lab work for PCOS profiles and STD diagnosis. KindlyHis’ sperm tests lets users take the test at home and then send it to a test center for diagnosis.»

«Kindly was founded in 2020 by Nilay Mehrotra, its CEO, and previously known as Mehrotra told TechCrunch that before taking part of Y Combinator’s winter 2022 cohort, Kindly was focused on fertility, specifically building a B2B tool for IVF clinics that would help them select the right embryo.»

Article written by Catherine Shu.